RecruitingNCT02749474

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being


Sponsor

The Cooper Health System

Enrollment

400 participants

Start Date

Jul 1, 2003

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.


Eligibility

Sex: FEMALE

Inclusion Criteria1

  • Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.

Exclusion Criteria1

  • Women diagnosed with cancer more than 6 months after the end of a pregnancy.

Locations(1)

Cooper University Hospital

Camden, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02749474